๐๐ฅ๐จ๐๐๐ฅ ๐ง๐ฎ๐๐ฅ๐๐๐ซ ๐ข๐ฆ๐๐ ๐ข๐ง๐ ๐๐ช๐ฎ๐ข๐ฉ๐ฆ๐๐ง๐ญ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐๐ญ ๐๐๐๐ ๐จ๐ ๐.๐๐% ๐ญ๐จ ๐ซ๐๐๐๐ก ๐๐๐๐๐๐๐.๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐. During pandemic, inpatient and outpatient services were affected, therefore, diagnostic and therapeutic nuclear medicine procedured dropped. However, growing geriatic population as well as increasing chronic illness such as cancer, cardiovascular diseases, neurological disorders, among others are driving the growth of the market throgh 2026.
In terms of product type, global nuclear imaging equipment market is segregated into PET Imaging Systems and Gamma Camera Imaging Systems. The PET imaging system is expected to dominate the market and witness a higher growth as compared to Gamma Camera Imaging on account of the ability of the PET imaging system to provide high-resolution images.
Furthermore, PET imaging systems provide higher diagnostic accuracy and lower patient exposure to radioactive particles. Additionally, PET imaging systems have the capability of generating images of the chemical alterations happening within the tissues, such as sugar metabolism. PET can also provide quantitative estimates of blood flow. Global nuclear imaging equipment market is fragmented with companies such as Siemens Healthineers AG, GE Healthcare, Koninklijke Philips NV and Canon Medical Systems Corporation occupying 47% of the market share in 2021.